Search hospitals > Pennsylvania > Philadelphia
Children's Hospital of Philadelphia
Claim this profilePhiladelphia, Pennsylvania 19104
Global Leader in Cancer
Global Leader in Adult T-Cell Leukemia/Lymphoma
Conducts research for Brain Tumor
Conducts research for Post-Implantation Syndrome
Conducts research for Acute Lymphoblastic Leukemia
1798 reported clinical trials
169 medical researchers
Summary
Children's Hospital of Philadelphia is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Cancer, Adult T-Cell Leukemia/Lymphoma, Brain Tumor, Post-Implantation Syndrome, Acute Lymphoblastic Leukemia and other specialties. Children's Hospital of Philadelphia is involved with conducting 1,798 clinical trials across 1,852 conditions. There are 169 research doctors associated with this hospital, such as Theodore W. Laetsch, Frank M Balis, Michael J Fisher, MD, and Nancy J Bunin, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
NTRK positive
2Adult T-Cell Leukemia/Lymphoma
Global LeaderCD19 positive
BCR-ABL1 positive
Stage II
Top PIs
Theodore W. LaetschChildren's Hospital of Philadelphia2 years of reported clinical research
Expert in Cancer
Expert in Soft Tissue Sarcoma
32 reported clinical trials
48 drugs studied
Frank M BalisChildren's Hospital of Philadelphia8 years of reported clinical research
Expert in Cancer
Expert in Soft Tissue Sarcoma
20 reported clinical trials
39 drugs studied
Michael J Fisher, MDChildren's Hospital of Philadelphia5 years of reported clinical research
Expert in Brain Tumor
Studies Diffuse Intrinsic Pontine Glioma
18 reported clinical trials
29 drugs studied
Nancy J Bunin, MDChildren's Hospital of Philadelphia7 years of reported clinical research
Studies Primary Immunodeficiency
Studies Glut1 Deficiency Syndrome
15 reported clinical trials
18 drugs studied
Clinical Trials running at Children's Hospital of Philadelphia
Chronic Kidney Disease
Crohn's Disease
Testicular cancer
Acute Lymphoblastic Leukemia
Kidney Disorders
Adult T-Cell Leukemia/Lymphoma
Wilms Tumor
Sepsis
Autism Spectrum Disorder
Sickle Cell Disease
Finerenone
for Pediatric Chronic Kidney Disease
This trial tests finerenone, a new medication added to existing treatments, to help children with chronic kidney disease (CKD) and proteinuria. It aims to see if finerenone can better control kidney function and reduce protein in the urine. The study will monitor safety and effectiveness over several months. Finerenone has been shown to delay the progression of chronic kidney disease.
Recruiting3 awards Phase 37 criteria
Oral Iron
for Chronic Kidney Disease
This trial tests iron pills in children with kidney disease and mild anemia. It aims to see if taking iron improves their muscle strength, activity levels, and eating habits. The study compares children taking iron pills to those who do not over a few months.
Recruiting3 awards Phase 45 criteria
Etelcalcetide
for Secondary Hyperparathyroidism
This is a Phase 3 Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
Recruiting2 awards Phase 38 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Children's Hospital of Philadelphia?
Where is Children's Hospital of Philadelphia located?
Who should I call to ask about financial aid or insurance network?
What insurance does Children's Hospital of Philadelphia accept?
What awards or recognition has Children's Hospital of Philadelphia received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.